Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Antibody Drug Conjugate
100%
Xenograft
62%
B Cell
60%
Chondroitin Sulfate Proteoglycan
60%
Immunoglobulin E
55%
Immunotherapy
42%
Tumor Antigen
37%
Immunoglobulin E Antibody
36%
Cancer Cell
33%
Molecular Imaging
30%
Antibody Structure
30%
B-Cell Receptor
30%
Immunoglobulin G1
30%
Chimeric Antigen Receptor T-Cell
30%
Autoimmunity
30%
Disease Burden
30%
Cancer Tissue
30%
Tumor Cell
27%
Immunocompetent Cell
24%
Isotype
23%
Cell Growth
23%
Cell Membrane
21%
Leukemia Cell
20%
RNAI
20%
Lymph Node
20%
Cell Migration
20%
Integrin
20%
Overall Survival
15%
Monoclonal Antibody
15%
Normal Human
15%
Adjuvant
15%
Antibody-Dependent Cell-Mediated Cytotoxicity
15%
Tumor Volume
15%
Survival Rate
15%
Cell Killing
15%
Single Photon Emission Computed Tomography
12%
Plasma Clearance
12%
Trastuzumab
12%
Effector Cell
10%
Cytotoxicity
10%
Dynamics
9%
Chemokine Receptor
9%
Folate Metabolism
9%
Cell Death
9%
Signal Transduction
9%
Mediator
9%
Growth Regulation
9%
Chemokine
9%
Antineoplastic Activity
9%
Humoral Immunity
8%
Medicine and Dentistry
Folate Receptor 1
60%
Antifolate
36%
Neoplasm
34%
Antibody-Drug Conjugate
33%
B Cell
30%
Guanosine Triphosphatase
30%
B-Cell Chronic Lymphocytic Leukemia
30%
Proteochondroitin Sulfate
30%
Melanoma
30%
Triple Negative Breast Cancer
30%
Antibody Therapy
30%
Ovarian Cancer
30%
Disease Burden
30%
Cancer Tissue
30%
B Lymphocyte Receptor
22%
Leukemia Cell
15%
Integrin
15%
Cell Migration
15%
Lymph Node
15%
In Vitro
12%
Receptor
10%
Immunoglobulin G1
9%
Cell Growth
9%
Xenograft
9%
Tumor Cell
9%
Disease Exacerbation
7%
Kinase
7%
Chemokine
7%
Chemokine Receptor
7%
Lymphatic Tissue
7%
RNAI
6%
Breast Cancer
6%
Immunocompetent Cell
6%
Tumor Xenograft
6%
Immunotherapy
6%
Volunteer
6%
Pharmacology, Toxicology and Pharmaceutical Science
Antibody Drug Conjugate
93%
Folate Receptor 1
60%
Neoplasm
43%
Folic Acid Antagonist
36%
Antibody Structure
30%
Proteochondroitin Sulfate
30%
Melanoma
30%
Triple Negative Breast Cancer
30%
Diseases
30%
Ovary Cancer
30%
Malignant Neoplasm
27%
Streptavidin
24%
Breast Cancer
18%
Trastuzumab
12%
Biotin
12%
Immunoglobulin G1
9%
Chemotherapy
6%
Immunotherapy
6%
Saporin
6%
Antitumor Activity
6%
Combination Therapy
6%
Antibody Conjugate
6%
Immunotoxin
6%
Trastuzumab Emtansine
6%